Comparing survival rates in endometrial cancer patients after laparoscopic hysterectomy with and without a uterine manipulator
Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator
This study looks at whether using a uterine manipulator during laparoscopic surgery for endometrial cancer helps patients live longer and stay cancer-free compared to those who don’t use it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 108 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | Female |
| Sponsor | Gaziosmanpasa Research and Education Hospital Government |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06307886 on ClinicalTrials.gov |
What this trial studies
This study compares the five-year survival and disease-free survival rates of patients diagnosed with endometrial cancer who underwent total laparoscopic hysterectomy, with some patients using a uterine manipulator and others not. It aims to determine if the use of a uterine manipulator during surgery affects long-term outcomes. The study is observational and will analyze data from patients aged 18 to 75 diagnosed with FIGO stage 1 and 2 endometrial cancer. The findings could provide insights into surgical techniques and their impact on patient prognosis.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 18 to 75 diagnosed with FIGO stage 1 and 2 endometrial cancer who are suitable for laparoscopic surgery.
Not a fit: Patients diagnosed with FIGO stage 3 and 4 endometrial cancer or those not suitable for laparoscopic surgery will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help refine surgical approaches for endometrial cancer, potentially improving patient survival and quality of life.
How similar studies have performed: While this study's specific approach is not widely tested, similar studies have shown varying outcomes regarding surgical techniques in cancer treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients suitable for laparoscopic surgery patients ages 18-75 patients diagnosed figo stage 1 and 2 endometrial cancer Exclusion Criteria: * patients not suitable for laparoscopic surgery patients diagnosed figo stage 3 and 4 endometrial cancer pregnant patients
Where this trial is running
Istanbul
- Gaziosmanpasa Training and research hospital — Istanbul, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Süleyman Salman, Professor
- Email: sleymansalman@gmail.com
- Phone: +905059345470
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.